Notice of Amendment: Prescription Drug List (PDL): Epinephrine (topical solution)

The purpose of this Notice of Amendment is to notify that Health Canada will add Epinephrine topical solution for hemostasis when sold at a concentration equal to or greater than 1 mg/ml (1:1000) to the Prescription Drug List (PDL). Both the Human and the Veterinary parts of the PDL were revised.

Data and Resources

Additional Info

Field Value
Source
Version
Author
Author Email
Maintainer
Maintainer Email
Data Level
Agreement Required
Purpose Constraints
Redistribution Allowed
AI Training Allowed
Data Steward
Title (French) Avis de modification : Liste des drogues sur ordonnance : Épinéphrine (solution topique)
Update Frequency as_needed
Geographic Scope []
Criticality Level []
Sensitivity Level unrestricted
Language
Contact Person
Contact Email
Data Dictionary
Open Canada Date Published 2021-12-01 00:00:00
Open Canada Date Modified
Open Canada Subject ["health_and_safety"]
Open Canada Keywords {"fr": ["avis de modification", "liste de médicaments sur ordonnance", "PDL", "solution topique d'épinéphrine"], "en": ["notice of amendment", "prescription drug list", "PDL", "epinephrine topical solution"]}
Open Canada Collection publication
Principal Organization
Reference Data
Official Source